Oragenics (OGEN) PT Lowered to $2.25 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts OGEN Hot Sheet
Price: $0.53 --0%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 17
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 17
Join SI Premium – FREE
Ascendiant Capital analyst Edward Woo lowered the price target on Oragenics (NYSE: OGEN) to $2.25 (from $2.50) while maintaining a Buy rating.
You May Also Be Interested In
- AEON Biopharma, Inc (AEON) PT Lowered to $1.20 at H.C. Wainwright
- GB Group Plc. (GBG:LN) PT Lowered to GBP3.45 at Deutsche Bank
- Indigo Paints (INDIGOPN:IN) PT Raised to INR975 at Kotak
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
